Evidence map›Paper›PMID 38241504›Full record

ArticleCancer biotherapy & radiopharmaceuticals2024

Unraveling Interaction of Rhenium-188 Microspheres with Primary Hepatic Cancer Cell: A Breakthrough Study.

Aarti Aggarwal, Gurjeet Kaur, Ravjit Singh Jassal, Bikash Medhi, Bhagwant Rai Mittal, Jaya Shukla

Registry-linked trialOpen access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer biotherapy & radiopharmaceuticals, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07436988 (Multicentric Study on Indigenous and Affordable Microspheres for Selective Internal Radiation Therapy), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07436988 phase1not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Multicentric Study on Indigenous and Affordable Microspheres for Selective Internal Radiation Therapy (SIRT) of Unresectable Liver Cancer

TypeinterventionalSponsorPost Graduate Institute of Medical Education and Research, ChandigarhRan2026 to 2028Enrolled18ConditionsHepatecellular CarcinomaArms90Y-Theraspheres, 188Re-Microspheres
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Challenges and Opportunities in Radioligand Therapy.Journal of nuclear medicine technology · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Aarti AggarwalDepartment of Nuclear Medicine, PGIMER Chandigarh, Chandigarh, India.
Gurjeet KaurDepartment of Pharmacology, PGIMER Chandigarh, Chandigarh, India.
Ravjit Singh JassalDepartment of Biochemistry, PGIMER Chandigarh, Chandigarh, India.
Bikash MedhiDepartment of Pharmacology, PGIMER Chandigarh, Chandigarh, India.
Bhagwant Rai MittalDepartment of Nuclear Medicine, PGIMER Chandigarh, Chandigarh, India.
Jaya ShuklaDepartment of Nuclear Medicine, PGIMER Chandigarh, Chandigarh, India.ORCID 0000-0003-3355-4168
Post Graduate Institute of Medical Education and Research · INChandigarh University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsRheniumAnnexin A5ApoptosisFluoresceinFluorescein-5-isothiocyanateHumansMicrospheresRadioisotopesAnnexin A5FluoresceinFluorescein-5-isothiocyanateRadioisotopesRheniumRhenium-188188Re microspheresapoptosisconfocal microscopyflow cytometryhepatocellular carcinoma

Identifiers

PMID38241504
PMCPMC11035844
OpenAlexW4391017389

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.